Small molecule · Inhibitor of methionine adenosyltransferase II alpha (MAT2A)
Phase 1/2Most advanced trial
1Registered trials
What is S-095035?
S-095035 is an orally bioavailable inhibitor of methionine adenosyltransferase II alpha (MAT2A), the enzyme that produces S-adenosyl-L-methionine, a primary methyl donor for cellular transmethylation. It is being studied in MTAP-deleted solid tumors, which depend heavily on MAT2A activity.
Summary written with AI from the sources listed at the end of this page.
At a glance
Drug type
Small molecule
Targets
methionine adenosyltransferase II alpha (MAT2A)
Mechanism
Inhibitor of methionine adenosyltransferase II alpha (MAT2A)
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z
This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.